National News
NAFDAC halts Artemether/Lumefantrine registration
The National Agency for Food and Drug Administration and Control (NAFDAC) has halted the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension.
The announcement was made in a public alert No. 01/2025, released on the agency’s website yesterday.
NAFDAC explained that the decision was made due to the instability of the reconstituted formulations, which could lead to a loss of efficacy over time.
According NAFDAC, the suspension applies to all locally manufactured and imported Multi-Dose Artemether/Lumefantrine dry powder for oral use.
“NAFDAC will no longer accept new applications, renewals, or variations for this product.”
According to the Agency, stability studies revealed that reconstituted Artemether/Lumefantrine oral suspension becomes unstable after mixing, leading to a loss
Ifeoma Nwovu
-
National News1 day agoTinubu orders full investigation into deaths of 37 miners in NSCDC custody
-
News1 day agoAPC Campaign Council accuses Atiku of compromising Nigeria’s interests over Mambilla dispute
-
News1 day agoAppeal Court upholds NDC registration, says Lokoja Court abused judicial power
-
News16 hours agoIGP Disu visits Niger, vows thorough probe into deaths of 37 miners in NSCDC custody
-
National News2 days agoMacron hosts Tinubu to private dinner in Paris (Photos)
-
News1 day agoGov Bago orders immediate curfew in Minna as tension mounts over miners’ deaths
-
News1 day agoSoludo grants pardon to native doctor Akwa Okuko, gives him new role in Anambra
-
News1 day agoPolice rescue eight kidnap victims in Benue forest, one dies from injuries






